Tag: Diabetes: Type II
Risk for CKD, CVD Lower for Adults With Evidence of Type 2 Diabetes Remission
Significantly lower risks of chronic kidney disease, composite cardiovascular disease measure seen for those with any remission
Type 2 Diabetes Remission Likely With Weight Loss After Diagnosis
Increased likelihood of diabetes remission and reduced risk for returning to hyperglycemia seen with weight loss in year after diagnosis
Healthful Plant-Based Diet May Lower Risk for Type 2 Diabetes
Association with lower risk for T2DM partially mediated by lower BMI, lower waist circumference, and lower HbA1c, triglycerides
Risk for Suicidal Ideation Not Increased With Semaglutide
No increased risk for suicidal ideation seen with semaglutide versus non-GLP1R agonist antiobesity medications
Dapagliflozin Cuts Cardiovascular Events in Patients With Heart Failure, T2D
However, dapagliflozin does not reduce urinary albumin-to-creatinine ratio in these patients
Treatment Modification Common With Second-Line Antidiabetic Meds
Lowest adjusted risk of switching and highest intensification risk for patients prescribed sufonylureas
Use of Noninsulin Antidiabetic Meds Increasing for T2D in Pregnancy
Use of noninsulin meds not linked to significantly increased risk for major congenital malformations
Metformin Added to Insulin Not Beneficial for T2D in Pregnancy
No significant difference seen in composite adverse neonatal outcome for patients receiving metformin or placebo in addition to insulin
Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D
GLP-1 receptor agonists linked to reduced risk for CRC compared with other antidiabetics, including insulin and metformin
Earlier Age at Menarche Raises Type 2 Diabetes Risk
Additionally, among women with diabetes, earlier age at menarche tied to increased stroke risk
